Female patients with Overactive bladder
Conditions
Interventions
control group:Tolterodine 2mg, qd
experimental group:Magnetic stimulation therapy
Sponsors
The Second Affiliated Hospital of Zhejiang Chinese Medicine University
Eligibility
Sex/Gender
Female
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Women aged 25-50 years; 2. Patients with negative urine culture and oabss score of 3-11 (mild to moderate), including 2 for urgency of urination and 1 for urgency of incontinence; 3. Patients with a course of more than 3 months; 4. Patients who had not used any drugs for OAB within 3 months before inclusion; 5. Patients who can cooperate with treatment and follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients during pregnancy or preparing for pregnancy; 2. Patients with pelvic organ prolapse; 3. Patients with stress urinary incontinence or mixed urinary incontinence mainly with stress urinary incontinence; 4. Patients with acute and chronic Gynecology, urinary infection, interstitial cystitis, bladder stone, malignant tumor, urethral outlet obstruction, etc.; 5. Patients with a history of transurethral and pelvic surgery; 6. Patients in epilepsy stage; 7. Patients in the acute stage of bleeding at the stimulation site; 8. Patients with implanted metal or electronic instruments near the stimulation site; 9. Patients with serious heart disease or arrhythmia; 10. Patients with urinary retention, myasthenia gravis, ulcerative colitis, and narrow angle glaucoma * 11. Patients with polyuria and severe hepatorenal diseases; 12. Patients with mental and neurological disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24-hour urine pad test;24-hour urination diary;OABSS score;ICIQ-OAB;OAB-Q;Urodynamics; | — |
Countries
China
Contacts
Public ContactQing Hu
The Second Affiliated Hospital of Zhejiang Chinese Medicine University
Outcome results
None listed